SGLT2 inhibitors do not pose fracture risk
The use of sodium-glucose cotransporter 2 inhibitors (SGLT2i), either alone or in combination with other glucose-lowering medications (GLM), does not seem to exacerbate the risk of sustaining fractures, a new study has found.
